Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Steffen-Sebastian Bolz_2023
VIEWPOINTS

Steffen-Sebastian Bolz, CSO of Aphaia Pharma Shares Insights from the P-II Study for Chronic Weight Management in Individuals with Obesity

Shots: Steffen shared the details of the first patient enrolled in the P-II study of Aphaia Pharma’s lead product APH-012 to induce weight loss in individuals with obesity He briefed the PharmaShots team about the study design of the P-II trial and also elaborated on the results from the P-I studyThe interview shows how…
February 27, 2023

Read more

VIEWPOINTS_Dr. Philip M. Toleikis_2023
VIEWPOINTS

Dr. Philip M. Toleikis, President & CEO at Sernova Shares Insights on the Partnership with Evotec to Develop a ‘Functional Cure’ for Diabetes

Shots: Dr. Philip shared his views on the collaboration of Sernova with Evotec for iPSC-Based Beta cell replacement therapy to develop and commercialize a ‘Functional Cure’ for diabetes.  He also gave an overview on the benefits of Evotec’s iPSC-based insulin-producing beta cells on the next generation of Sernova’s Cell Pouch System The interview discusses about how Sernova…
February 7, 2023

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]